Implications of hyperglycaemia and ethnicity in patients with acute coronary syndromes in New Zealand

Diabetes, Obesity and Metabolism

Volumn 9, Issue 1, 2007, Pages 121-126

  Scott, Adrian R ^a,c   Cheng, A ^a   Greenacre, M ^b   Devlin, G ^a  

^a WAIKATO HOSPITAL   (New Zealand)

^b UNIVERSITAT POMPEU FABRA   (Spain)

^c NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Angina unstable; Diabetes mellitus; Ethnic groups; Hyperglycaemia; Maori; Myocardial infarction

Indexed keywords

GLUCOSE;

ACUTE CORONARY SYNDROME; ADULT; AGED; AGING; ARTICLE; DIABETES MELLITUS; DISEASE MARKER; ETHNOLOGY; EUROPE; FEMALE; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HOSPITALIZATION; HUMAN; HYPERGLYCEMIA; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MAORI; MORTALITY; NEW ZEALAND; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; ST SEGMENT ELEVATION;

EID: 33845515525     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2006.00597.x     Document Type: Article

References (29)

1. Rytter IR, Troelsen S, Beck-Nielsen H. Prevalence and mortality of acute myocardial infarctions in patients with diabetes. Diabetes Care 1985; 8: 230-234.
2. Otter W, Kleybrink S, Doering W, Standt E, Schnell O. Hospital outcome of acute myocardial infarction in patients with and without diabetes mellitus. Diabet Med 2004; 21: 183-187.
3. Fox CS, Sullivan L, D'Agostino RB, Wilson PWF. The significant effect of diabetes duration on coronary heart disease mortality. Diabetes Care 2004; 27: 704-708.
4. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339: 229-234.
5. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: A systematic overview. Lancet 2000; 355: 773-778.
6. Sewdarsen M, Vythilingum S, Jialal I, Kamdar MC. Prognostic importance of admission plasma glucose in diabetic and non-diabetic patients with acute myocardial infarction. Q J Med 1989; 71 (265): 461-466.
7. Bellodi G, Manicardi V, Malavasi V et al. Hyperglycaemia and prognosis of acute myocardial infarction in patients without diabetes mellitus. Am J Cardiol 1989; 64 (14): 885-888.
8. Oswald GA, Yudkin JS. Hyperglycaemia following acute myocardial infarction: The contribution of undiagnosed diabetes. Diabet Med 1987; 4: 68-70.
9. Hadjadj S, Coisne D, Mauco G et al. Prognostic value of admission plasma glucose and HbA1c in acute myocardial infarction. Diabet Med 2004; 21: 305-310.
10. Bolk J, van der Ploeg T, Cornel JH, Arnold AE, Sepers J, Umans VA. Impaired glucose metabolism predicts mortality after a myocardial infarction. Int J Cardiol 2001; 79: 207-214.
11. New Zealand Health Strategy. DHB toolkit: Cardiovascular disease, 2nd edn. Available from http://www.newhealth.govt.nz/toolkits/toolkits.htm.
12. Schnell O, Schafer O, Sonja K, Doering W, Standl E, Otter W. Intensification of therapeutic approaches reduces mortality in diabetic patients with acute myocardial infarction. Diabetes Care 2004; 27: 455-460.
13. Malmberg K. Prospective randomised study of intensive insulin treatment on long term survival after myocardial infarction in patients with diabetes mellitus. BMJ 1997; 314: 1512-1515.
14. Vikman S, Niemela K, Ilva T et al. Underuse of evidence-based treatment modalities in diabetic patients with non-ST elevation acute coronary syndrome. A prospective nation wide study on acute coronary syndrome (FINACS). Diabetes Res Clin Pract 2003; 61: 39-48.
15. Norhammar A, Malmberg K, Ryden L, Tornvall P, Stenestrand U, Wallentin L. Register of Information and Knowledge about Swedish Heart Intensive Care Admission (RIKS-HIA): Under utilisation of evidence-based treatment partially explains for the unfavourable prognosis in diabetic patients with acute myocardial infarction. Eur Heart J 2003; 24: 838-844.
16. Malmberg K, Ryden L, Wedel H et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): Effects on mortality and morbidity. Eur Heart J 2005; 26: 650-661.
17. Luscher MS, Thygesen K, Ravkilde J et al. Applicability of cardiac troponin T and I for early risk stratification in unstable coronary artery disease. Circulation 1997; 96: 2578-2585.
18. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined - a consensus document of the Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000; 36: 959-969.
19. Cox DR, Oakes D. Analysis of Survival Data. London: Chapman & Hall, 1984.
20. Norhammar AM, Ryden L, Malmberg K. Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients. Diabetes Care 1999; 22: 1827-1831.
21. Oliver MF, Opie LH. Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias. Lancet 1994; 343: 155-158.
22. Bartnik M, Malmberg K, Norhammar A, Tenerz A, Ohrvik J, Ryden L. Newly detected abnormal glucose tolerance: An important predictor of long-term outcome after myocardial infarction. Eur Heart J 2004; 25: 1990-1997.
23. Ellis C, Gamble G, French J et al. (for NZ Acute Coronary Syndromes [NZACS] Audit Group). Management of patients admitted with an Acute Coronary Syndrome in New Zealand: Results of a comprehensive nationwide audit. N Z Med J 2004; 117 (1197): U953.
24. Ellis C, Devlin GP, Matsis P et al. (for NZ Acute Coronary Syndromes [NZACS] Audit Group). Acute Coronary Syndrome patients in New Zealand receive less invasive management when admitted to hospitals without invasive facilities. N Z Med J 2004; 117 (1197): U954.
25. Devlin GP Anderson FA Jr, Heald SC et al. Management and outcomes of lower-risk patients presenting with acute coronary syndromes in a multinational observational registry. Heart 2005; 91 (11): 1394-1411. [Epub 2005].
26. Bertrand ME, Simoons ML, Fox KA et al. Management of acute coronary syndromes: Acute coronary syndromes without persistent ST segment elevation; recommendations of the Task Force of the European Society of Cardiology. Eur Heart J 2000; 21: 1406-1432.
27. Braunwald E, Antman EM, Beasley JW et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 2000; 36: 970-1062.
28. Gaede P, Vedel P, Larsen N, Jensen GVH, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003; 348: 383-393.
29. Franklin K, Goldberg RJ, Spencer F et al. Implications of diabetes in patients with acute coronary syndromes. Arch Intern Med 2004; 164: 1457-1463.